Clinical Trial Update: Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge [Phase 2]

View source ↗

Summary

Phase 2 study assessing a single dose of REGN1908-1909 to reduce bronchoconstriction after cat allergen exposure in cat-allergic patients with asthma; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Cat Allergy

Drugs mentioned

• REGN1908-1909

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Cat Allergy, Mild Asthma | Phase 2 | Status: COMPLETED | Results posted: 2021-07-01